Bhupesh Singla Has Been Elected As a Fellow of the American Heart Association – UTHSC College of Pharmacy
UTHSC (The University of Tennessee Health Science Center) College of Pharmacy shared a post on LinkedIn:
“Congratulations to Dr. Bhupesh Singla, Assistant Professor in the College of Pharmacy’s Department of Pharmaceutical Sciences, who has been elected as a Fellow of the American Heart Association (FAHA) by the Council on Arteriosclerosis, Thrombosis, and Vascular Biology.
This prestigious honorary title is awarded to physicians, scientists, nurses, and healthcare professionals who have demonstrated a sustained record of excellence and made significant contributions to cardiovascular and stroke research, clinical practice, education, and leadership.
Dr. Singla’s research investigates the role of matricellular proteins in the development and progression of cardiometabolic diseases, including atherosclerosis and metabolic dysfunction-associated steatotic liver disease.
Election as an FAHA recognizes Dr. Singla’s scientific distinction and expertise in cardiovascular research.
His research work has been published in high-impact journals, and he has a strong and consistent record of securing funding for basic science research, including a predoctoral fellowship, two postdoctoral fellowships, an NIH K99/R00 award, an NIH R01 grant, and several institutional intramural grants.
In addition to his research achievements, Dr. Singla is committed to mentoring trainees and actively contributes to service at the institutional, national, and international levels.
‘I am deeply honored to be elected as a Fellow of the American Heart Association,’ said Dr. Singla. ‘This recognition reflects the collective efforts and dedication of my trainees, collaborators, and mentors.’
The AHA is a leading voluntary health organization devoted to fighting cardiovascular disease and stroke.
Fellowship in the AHA recognizes not only scientific accomplishments but also dedication to the organization’s mission to build healthier lives free of cardiovascular disease and stroke.”
Stay updated with Hemostasis Today.
-
Jul 3, 2026, 09:33Abdul Mannan: Not All Type 1 VWD Starts in the VWF Gene
-
Jul 3, 2026, 09:18Aryabhatta Sadhu: Sickle Cell Crisis – When Diagnostics Should Change Therapy
-
Jul 3, 2026, 05:55New Evidence Supports Chromogenic Assays After Hemophilia A Gene Therapy – JTH
-
Jul 3, 2026, 05:50Jacopo Parizzi: Roche’s Non-Malignant Hematology Team Is Looking Ahead to 2027
-
Jul 3, 2026, 05:25Brian A Beh: A New Approach from The George Institute for Global Health Could Transform Stroke Care Before Hospital Arrival
-
Jul 3, 2026, 05:22Deirdre Finnigan: New Insights into Red Blood Cell Biomechanics in Cancer-Associated Anemia
-
Jul 3, 2026, 05:15Danielle Boyle: Collaboration Across Borders Is Helping Shape the Future of ITP Care
-
Jul 3, 2026, 05:05Claire McIvor: One Year at the Stroke Association and Grateful for a Workplace That Made It Possible
-
Jul 2, 2026, 23:11Michael Makris: Join The Cancer Associated Thrombosis Workshop at ISTH 2026